www.mhlw.go.jp/stf/houdou/0000062032.html
archives
This URL has 1 public saves. The first save was Apr 4, 2026, 06:02 PM and the latest save was Apr 4, 2026, 06:02 PM.
View recent saves on this domain
Latest saved version
C型慢性肝炎治療薬「ソブリアードカプセル100mg」に関し安全性速報（ブルーレター）を発出しました｜厚生労働省
This is the newest public snapshot for this URL and the best place to start reviewing the page.
Source URL
https://www.mhlw.go.jp/stf/houdou/0000062032.html
About this page
This page announces that the Ministry of Health, Labour and Welfare has issued a safety alert regarding the hepatitis C antiviral drug "Sobriard Capsule 100mg" due to reported deaths related to elevated bilirubin levels. Following three domestic fatality cases causally linked to the drug, the product labeling has been revised and healthcare providers have been instructed to provide immediate warnings. Key measures include regular blood bilirubin monitoring during treatment, discontinuation if abnormalities occur, continued observation after treatment cessation, and patient guidance to seek immediate medical consultation if symptoms such as jaundice or dark urine appear.
Saved versions
www.mhlw.go.jp/stf/houdou/0000062032.html web archives are listed here. You can still review the saved screenshot and HTML even if the original page disappears.